Joan Perramon Llussà
Research Subjects
Joan Perramon Llussà has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Karim Lekadir
Artificial Intelligence in Medicine Lab (BCN-AIM), Department of Mathematics and Computer Science, University of Barcelona, Barcelona, Spain
3 shared publications - Andreas Triantafyllidis
Information Technologies Institute, Centre for Research and Technology Hellas, 57001 Thessaloniki, Greece
2 shared publications - Carina Dantas
SHINE 2Europe, 3030-163 Coimbra, Portugal
2 shared publications - Folkert W. Asselbergs
Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
2 shared publications - Miriam Cabrita
SHINE 2Europe (Portugal), Rua Câmara Pestana Lote 3 - 1ºD/F, Coimbra, Coimbra, Portugal, +351936498277
2 shared publications - Polyxeni Gkontra
Artificial Intelligence in Medicine Lab (BCN-AIM), Departament de Matemàtiques i Informàtica, Universitat de Barcelona, Spain (J.P.-L., G.S., E.R.P., S.J.E.K., I.S., K.L., P.G.).
2 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 11 May 2026
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 19 (7) , e013823
Big Data and Trustworthy AI for Heart Failure: A Review
The rapid evolution of machine learning techniques, combined with the growing availability of large and diverse data sets, is poised to transform heart failure research and clinical care. This review first provides an overview of key machine learning and artificial intelligence concepts used in heart failure research and then examines how diverse data modalities—including electronic health records, patient registries, biobanks, imaging, telemonitoring, and synthetic data—are leveraged to develop machine learning applications for heart failure diagnosis, prognosis, risk stratification, and personalized treatment strategies. While the potential is considerable, we highlight key barriers to clinical translation, such as data heterogeneity, algorithmic bias, lack of interoperability, and privacy concerns. The review also examines the need for explainable and equitable artificial intelligence systems and evaluates emerging solutions, including Federated Learning and synthetic data generation to address fairness and data privacy challenges. Beyond technical innovations, we underscore the importance of human-centered design, stakeholder engagement, and regulatory readiness. We conclude by identifying future priorities and calling for interdisciplinary collaboration to ensure the scalable, ethical, and effective integration of AI in heart failure management.
- 11 May 2026
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 19 (7) , e013823
Top Cited PapersOpen AccessBig Data and Trustworthy AI for Heart Failure: A Review
The rapid evolution of machine learning techniques, combined with the growing availability of large and diverse data sets, is poised to transform heart failure research and clinical care. This review first provides an overview of key machine learning and artificial intelligence concepts used in heart failure research and then examines how diverse data modalities—including electronic health records, patient registries, biobanks, imaging, telemonitoring, and synthetic data—are leveraged to develop machine learning applications for heart failure diagnosis, prognosis, risk stratification, and personalized treatment strategies. While the potential is considerable, we highlight key barriers to clinical translation, such as data heterogeneity, algorithmic bias, lack of interoperability, and privacy concerns. The review also examines the need for explainable and equitable artificial intelligence systems and evaluates emerging solutions, including Federated Learning and synthetic data generation to address fairness and data privacy challenges. Beyond technical innovations, we underscore the importance of human-centered design, stakeholder engagement, and regulatory readiness. We conclude by identifying future priorities and calling for interdisciplinary collaboration to ensure the scalable, ethical, and effective integration of AI in heart failure management.
- 24 July 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-6
Integrating Participatory Research and Literature Review to Identify Social and Ethical Requirements for Responsible AI in Heart Failure Treatment
The rapid advancement of Artificial Intelligence (AI) in healthcare raises significant social and ethical concerns, particularly in cardiovascular care, the leading cause of death worldwide. Addressing these challenges requires a multidisciplinary, multi-stakeholder approach to ensure the responsible development and implementation of AI-driven solutions. First, a literature review examined how key ethical principles - namely, autonomy, confidentiality, data privacy, and equal treatment - are integrated into AI applications for heart failure care. These findings informed an online workshop with patient representatives, clinicians, and experts on ethical, legal, and social issues to discuss ethical concerns and practical implications. A team of requirements engineers and digital health experts synthesized insights from the literature review and workshop, specifying an initial set of requirements. Following multiple iterations with a multidisciplinary review team, the final set of 25 requirements was established. These were translated into software or system specifications where applicable or used to define guidelines for real-world implementation. This study provides a structured approach to embedding ethical and social considerations into AI-driven healthcare solutions. Its methods and key requirements are transferable to other AI applications in public health, promoting responsible and equitable adoption.
- 24 July 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-6
Integrating Participatory Research and Literature Review to Identify Social and Ethical Requirements for Responsible AI in Heart Failure Treatment
The rapid advancement of Artificial Intelligence (AI) in healthcare raises significant social and ethical concerns, particularly in cardiovascular care, the leading cause of death worldwide. Addressing these challenges requires a multidisciplinary, multi-stakeholder approach to ensure the responsible development and implementation of AI-driven solutions. First, a literature review examined how key ethical principles - namely, autonomy, confidentiality, data privacy, and equal treatment - are integrated into AI applications for heart failure care. These findings informed an online workshop with patient representatives, clinicians, and experts on ethical, legal, and social issues to discuss ethical concerns and practical implications. A team of requirements engineers and digital health experts synthesized insights from the literature review and workshop, specifying an initial set of requirements. Following multiple iterations with a multidisciplinary review team, the final set of 25 requirements was established. These were translated into software or system specifications where applicable or used to define guidelines for real-world implementation. This study provides a structured approach to embedding ethical and social considerations into AI-driven healthcare solutions. Its methods and key requirements are transferable to other AI applications in public health, promoting responsible and equitable adoption.
- 13 November 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
Enhancing Heart Failure Management: Integrating AI with Telemonitoring Systems for Advanced Alarm-Based Solutions
Heart failure (HF) poses significant global health challenges, necessitating advanced management strategies. Telemonitoring, coupled with artificial intelligence (AI), offers a promising approach to enhance HF care by remotely monitoring patients and predicting exacerbations. This paper introduces vitalera, a telemonitoring platform integrating AI to optimize patient management through personalized health data analysis and smart alarms. Key to our study is the improvement of vitalera's alarm-based system using machine learning models. An ongoing observational clinical study across hospitals in Spain and Romania provides data for training and validating the system. Initial results using traditional Machine Learning (ML) models evaluated by means of cross-validation show promising performance, achieving high recall rates crucial for timely detection of critical alarms and outperforming the current rule-based system. Challenges include optimizing model performance across varied hospital contexts and managing dataset imbalance. This study underscores AI's potential in revolutionizing HF telemonitoring, aiming for enhanced patient outcomes and quality of care.
- 13 November 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
Enhancing Heart Failure Management: Integrating AI with Telemonitoring Systems for Advanced Alarm-Based Solutions
Heart failure (HF) poses significant global health challenges, necessitating advanced management strategies. Telemonitoring, coupled with artificial intelligence (AI), offers a promising approach to enhance HF care by remotely monitoring patients and predicting exacerbations. This paper introduces vitalera, a telemonitoring platform integrating AI to optimize patient management through personalized health data analysis and smart alarms. Key to our study is the improvement of vitalera's alarm-based system using machine learning models. An ongoing observational clinical study across hospitals in Spain and Romania provides data for training and validating the system. Initial results using traditional Machine Learning (ML) models evaluated by means of cross-validation show promising performance, achieving high recall rates crucial for timely detection of critical alarms and outperforming the current rule-based system. Challenges include optimizing model performance across varied hospital contexts and managing dataset imbalance. This study underscores AI's potential in revolutionizing HF telemonitoring, aiming for enhanced patient outcomes and quality of care.
- 13 November 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
Requirements for Human-Centered Artificial Intelligence: A Heart Failure Study Across Europe and Latin America
This paper explores the requirements for humancentered artificial intelligence (AI) tools for heart failure (HF) management, focusing on the needs of diverse healthcare settings in selected European countries (Netherlands, Spain, Czech Republic) and a Latin American country (Peru). Clinicians, patients, ethicists, and technical experts were engaged through cocreation workshops, local groups, narrative interviews, and surveys to gather clinical, ethical, and regulatory requirements for AI implementation in HF care. These activities provided input on the intended clinical use of AI tools, as well as patient data privacy and security concerns. Clinical requirements revealed regional differences in AI tool preferences and key predictors. European clinicians favored integration into secondary and tertiary care, focusing on quality of life and comprehensive follow-up measures, while clinicians in Peru prioritized secondary care with an emphasis on treatment adherence and complication management. Ethical considerations, such as data privacy and bias mitigation, were universally important but some context-specific differences emerged. European stakeholders emphasized mitigating biases related to sex, ethnicity, and socioeconomic status under European regulations, whereas Latin American stakeholders focused on context-specific ethics and robust national oversight. By aligning these insights with FUTURE-AI principles, the study ensures the development of effective, human-centered AI tools. This research highlights the importance of continuous stakeholder engagement and contextualizing AI applications to enhance their relevance, usability, and adoption across diverse healthcare settings.
- 13 November 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-4
Requirements for Human-Centered Artificial Intelligence: A Heart Failure Study Across Europe and Latin America
This paper explores the requirements for humancentered artificial intelligence (AI) tools for heart failure (HF) management, focusing on the needs of diverse healthcare settings in selected European countries (Netherlands, Spain, Czech Republic) and a Latin American country (Peru). Clinicians, patients, ethicists, and technical experts were engaged through cocreation workshops, local groups, narrative interviews, and surveys to gather clinical, ethical, and regulatory requirements for AI implementation in HF care. These activities provided input on the intended clinical use of AI tools, as well as patient data privacy and security concerns. Clinical requirements revealed regional differences in AI tool preferences and key predictors. European clinicians favored integration into secondary and tertiary care, focusing on quality of life and comprehensive follow-up measures, while clinicians in Peru prioritized secondary care with an emphasis on treatment adherence and complication management. Ethical considerations, such as data privacy and bias mitigation, were universally important but some context-specific differences emerged. European stakeholders emphasized mitigating biases related to sex, ethnicity, and socioeconomic status under European regulations, whereas Latin American stakeholders focused on context-specific ethics and robust national oversight. By aligning these insights with FUTURE-AI principles, the study ensures the development of effective, human-centered AI tools. This research highlights the importance of continuous stakeholder engagement and contextualizing AI applications to enhance their relevance, usability, and adoption across diverse healthcare settings.